Blood sample
Blood sample is an intervention with 684 clinical trials. Currently 157 active trials ongoing. Historical success rate of 91.0%.
Success Metrics
Based on 332 completed trials
Phase Distribution
Phase Distribution
11
Early Stage
13
Mid Stage
23
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.3%
332 of 376 finished
11.7%
44 ended early
157
trials recruiting
684
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC)
Study of the Hypothalamic Microglial Response as a Function of a Meal's Lipid Content in Humans. A Single-center Prospective Cohort Study in Healthy Male Subjects
A Study of the Value of Trio Genome Sequencing in the Etiological Evaluation of Early-Onset and/or Atypical Psychiatric Disorders Without Intellectual Disability or Congenital Anomalies
Study of the Impact of Phosphate Supplementation on FGF23 Concentrations in Patients With Hypophosphatemia
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
Clinical Trials (684)
Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC)
Study of the Hypothalamic Microglial Response as a Function of a Meal's Lipid Content in Humans. A Single-center Prospective Cohort Study in Healthy Male Subjects
A Study of the Value of Trio Genome Sequencing in the Etiological Evaluation of Early-Onset and/or Atypical Psychiatric Disorders Without Intellectual Disability or Congenital Anomalies
Study of the Impact of Phosphate Supplementation on FGF23 Concentrations in Patients With Hypophosphatemia
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers)
Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology
Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer
The Potential of Mesenchymal Stromal Stem Cells to Correct Immune and Metabolic Dysfunctions in Circulating Immune Cells During Sepsis: An Ex Vivo Pilot Study.
Assessing Brain Metabolism Using MRS With Deuterated Glucose
UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations
Screening for Oculocerebral Lymphoma With the Phenotype of NK Cells in Patients With Uveitis
Characterization of Extracellular Vesicles in Breast Cancer Patients
Biopsychosocial Markers of Addiction in Opioid Users: an Integrated Approach
New Biological Tests in Patients With Antiphospholipid Antibodies
Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
Metabolic and Cognitive Parameters Following Partial Sleep Deprivation
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 684